F. Gentili

发表

Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.

L. Mattioli, F. Gentili, C. Cardinaletti, 2006, European journal of pharmacology.

Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.

C. Melchiorre, G. Marucci, A. Carotti, 2002, Journal of medicinal chemistry.

Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models.

L. Brasili, M. Dontenwill, F. Leonetti, 1998, Bioorganic & medicinal chemistry.

Binding of Tracizolines to the Imidazoline Receptor: Role of Lipophilicity in Quantitative Structure‐Activity Relationship Models a

L. Brasili, M. Dontenwill, F. Leonetti, 1999, Annals of the New York Academy of Sciences.

α2-Adrenoreceptors Profile Modulation. 2.1 Biphenyline Analogues as Tools for Selective Activation of the α2C-Subtype

M. Giannella, A. Piergentili, W. Quaglia, 2004 .

Alpha2-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole.

G. Marucci, L. Brasili, M. Dontenwill, 2002, Journal of medicinal chemistry.

Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions.

A. Hudson, L. Mattioli, M. Giannella, 2008, Journal of medicinal chemistry.

Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline.

S. Franchini, G. Marucci, L. Brasili, 2000, Bioorganic & medicinal chemistry.

Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate

Mario Giannella, Alessandro Piergentili, Wilma Quaglia, 2005, Journal of medicinal chemistry.

Hyperphagic effect of novel compounds with high affinity for imidazoline I(2) binding sites.

C. Polidori, M. Massi, W. Quaglia, 2000, European journal of pharmacology.

Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues.

L. Brasili, M. Dontenwill, J. Feldman, 2003, Journal of Medicinal Chemistry.

(S)-(+)-2-[2-(Biphenyl-2-yl)-1-methylethyl]-4,5-dihydro-1H-imidazolium hydrogen oxalate

L. Messori, M. Giannella, F. Gentili, 2005 .

Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine.

G. Marucci, M. Giannella, A. Piergentili, 2003, Bioorganic & medicinal chemistry.

14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry

G. Marucci, M. Giannella, G. Giorgioni, 2003 .

3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor.

P. Renard, S. Marchal-Victorion, P. Delagrange, 2006, Journal of medicinal chemistry.

Agonists and Antagonists Targeting the Different α2-Adrenoceptor Subtypes

M. Giannella, A. Piergentili, F. Gentili, 2007 .

Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.

M. Scheinin, J. Laurila, M. Giannella, 2008, Journal of medicinal chemistry.